Procter & Gamble Hygiene and Health Care · NSE: PGHH · BSE: 500459
Q2 FY25 results · Jul–Sep 2024
Procter & Gamble Hygiene and Health Care reported revenue from operations of ₹1,135.16 crore (down 0.3% from Q2 FY24) and net profit of ₹211.90 crore (up 0.6% from Q2 FY24) for Q2 FY25 (Jul–Sep 2024), on a standalone basis.
| Item | Q2 FY25 | Q2 FY24 | YoY | Q1 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,135.16 | 1,138.35 | −0.3% | 931.75 | +21.8% |
| Other income | 8.50 | 15.77 | −46.1% | 7.31 | +16.3% |
| Total income | 1,143.66 | 1,154.12 | −0.9% | 939.06 | +21.8% |
| Profit before tax | 285.37 | 284.47 | +0.3% | 112.28 | +154.2% |
| Net profit for the period | 211.90 | 210.69 | +0.6% | 81.06 | +161.4% |
| EPS, basic (₹) | 65.28 | 64.91 | +0.6% | 24.97 | +161.4% |
| Net margin (%) | 18.7 | 18.5 | 8.7 |
Standalone
- Filed with BSE
- 30 Oct 2024, 13:27 IST
- Board meeting
- 30 Oct 2024
- Period
- 01 Jul 2024 to 30 Sep 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE